Elevated cTnT is commonly present in stable COPD without overt coronary vascular disease, and is associated with higher mortality, irrelevantly to the severity of COPD and other cardiovascular risk factors. This evidence concerns the gene TNNT2 and chronic obstructive pulmonary disease.